These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11364287)

  • 1. Advanced AIDS treatment.
    Treat Rev; 1997 Apr; (No 24):7. PubMed ID: 11364287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
    Jacobson JM; Lederman MM; Spritzler J; Valdez H; Tebas P; Skowron G; Wang R; Jackson JB; Fox L; Landay A; Gilbert MJ; O'Neil D; Bancroft L; Al-Harthi L; Jacobson MA; Merigan TC; Glesby MJ;
    J Infect Dis; 2003 Dec; 188(12):1804-14. PubMed ID: 14673758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three drug combo halves AIDS deaths.
    Treat Rev; 1997 Apr; (No 24):2-4. PubMed ID: 11364283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of GM-CSF in patients with AIDS: a review of the literature.
    Ross SD; DiGeorge A; Connelly JE; Whiting GW; McDonnell N
    Pharmacotherapy; 1998; 18(6):1290-7. PubMed ID: 9855329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of GM-CSF enrolling.
    Proj Inf Perspect; 1997 Jul; (22):14. PubMed ID: 11364571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug companies seek trial participants.
    AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. University of Washington AIDS clinical trials unit.
    STEP Perspect; 1995; 7(3):14-5. PubMed ID: 11362982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY; Xu B; Sun J; Yang Y; Niu JN
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Philadelphia area AIDS/HIV clinical trials.
    Crit Path AIDS Proj; 1998; (No 33):35-43. PubMed ID: 11366372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LEUKINE maintains viral suppression and extends duration of antiretroviral therapy.
    AIDS Patient Care STDS; 1999 Sep; 13(9):568-9. PubMed ID: 10813042
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic disease and other condition studies open for enrollment--August 1996. University of Washington AIDS Clinical Trials Unit.
    STEP Perspect; 1996; 8(2):18-9. PubMed ID: 11364262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filgrastim: new indication. AIDS-associated neutropenia: another soft indication.
    Prescrire Int; 2001 Aug; 10(54):106-7. PubMed ID: 11718177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. List of studies - October 1997. University of Washington AIDS Clinical Trials Unit.
    STEP Perspect; 1998; 98(1):24-5. PubMed ID: 11365213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neupogen and AIDS: the next frontier.
    Marks S
    J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):38-9. PubMed ID: 11363744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection.
    de Silva TI; Cope A; Goepel J; Greig JM
    J Infect; 2007 Apr; 54(4):e207-10. PubMed ID: 17197031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. List of studies - October 1996. University of Washington AIDS Clinical Trials Unit.
    STEP Perspect; 1996; 8(3):17-8. PubMed ID: 11364266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.